Molina J Ernesto, Hunter David W, Dietz Charles A
Department of Surgery, Divisions of Cardiothoracic Surgery and Interventional Radiology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
J Vasc Surg. 2007 Feb;45(2):328-34. doi: 10.1016/j.jvs.2006.09.052.
Reviewed are the results of the emergent treatment of effort thrombosis of the subclavian vein. The protocol calls for immediate thrombolysis, followed by surgery at the time of the acute event. The one-stage procedure includes decompression of the thoracic inlet by subclavicular removal of the first rib, subclavius muscle, scalenectomy, and vein patch plasty of the stenotic segment of the vein.
Between July 1985 through June 2006, 114 patients presented with Paget-Schroetter syndrome (effort thrombosis of the subclavian vein), 97 of which (group I) were seen < or =2 weeks of onset of symptoms. They underwent an emergent protocol treatment in which thrombolysis is immediately followed by surgery at the time of the acute event. In addition, another 17 patients (group II) were referred to our institution after being treated elsewhere with initial thrombolysis, but with surgery deferred a mean 34 days (range, 2 weeks to 3 months) after the initial event. All patients underwent the same lytic and surgical protocol. Operability was determined by the findings on the venogram. Routine postoperative anticoagulation for 8 weeks was implemented with warfarin and clopidogrel.
There was 100% success in re-establishing the flow and normal caliber of the subclavian vein in the 97 patients in group I. Seven patients showed some residual stenosis that required balloon plasty and implant of a stent. Postoperative duplex ultrasound imaging documented patency in all 97 patients (100%). The 17 patients with delayed surgery (group II) showed progression of the fibrosis, with vein obstruction in 12 (70%). Only five patients (29%) were operable with successful results. The remaining 12 patients were inoperable owing to extensive fibrosis and occlusion of the inflow, and all 12 have remained disabled for the use of their arm.
The emergent approach to treat Paget-Schroetter syndrome seems to render the optimal results, with 100% effectiveness in re-establishing venous flow and normal caliber to the vessel. When properly conducted, this operation avoids the use of stents or balloon plasty with excellent long-term results, leaving the patients unrestricted for physical activities.
回顾了锁骨下静脉用力性血栓形成的急诊治疗结果。该方案要求立即进行溶栓治疗,随后在急性事件发生时进行手术。一期手术包括通过锁骨下切除第一肋、锁骨下肌、斜角肌切除术以及对静脉狭窄段进行静脉补片成形术来减压胸廓入口。
在1985年7月至2006年6月期间,114例患者出现佩吉特 - 施罗特综合征(锁骨下静脉用力性血栓形成),其中97例(I组)在症状出现≤2周时就诊。他们接受了急诊方案治疗,即在急性事件发生时立即进行溶栓治疗,随后进行手术。此外,另有17例患者(II组)在其他地方接受初始溶栓治疗后转诊至我院,但手术在初始事件后平均推迟34天(范围为2周至3个月)。所有患者均接受相同的溶栓和手术方案。根据静脉造影结果确定可操作性。术后使用华法林和氯吡格雷进行8周的常规抗凝治疗。
I组的97例患者中,100%成功重建了锁骨下静脉的血流和正常管径。7例患者显示有一些残余狭窄,需要球囊成形术和植入支架。术后双功超声成像显示所有97例患者(100%)血管通畅。17例延迟手术的患者(II组)显示纤维化进展,12例(70%)出现静脉阻塞。只有5例患者(29%)可进行手术且结果成功。其余12例患者因广泛纤维化和流入道阻塞而无法手术,所有12例患者的患侧手臂均无法正常使用。
治疗佩吉特 - 施罗特综合征的急诊方法似乎能取得最佳效果,在重建静脉血流和血管正常管径方面的有效率为100%。如果操作得当,该手术可避免使用支架或球囊成形术,长期效果良好,患者的身体活动不受限制。